When you form a startup and say “platform” every other sentence.
This week, Mayo Clinic—one of the largest and most prestigious health systems in the world—joined the club. It’s launching a platform designed to augment (human) clinical decision makers.
- Data: The system will tap into new patient data streams by using remote sensors and devices. Continuous monitoring provides more ironclad health signals than irregular collection methods, the thinking goes.
- AI: How do medical professionals interpret that data at scale? Why, they use advanced algorithms, of course!
Add it all up
More data + more AI = better diagnostics, earlier disease detection, and improved patient care. While we’ve heard this story many times before, Mayo is putting serious money behind the effort.
The healthcare nonprofit has formed two new startups, Anumana and Lucem Health. Mayo Clinic and external investors have put nearly $32 million into the spinoffs. The marching orders: Go forth and commercialize the platform. Anumana has already said it will seek FDA approval for an AI product.
The real question: Is Big Tech knocking on Mayo Clinic’s door? Or vice versa?
Advantage Big Tech = More neural net experience on the resume.
Advantage Mayo = Proficient in healthcare. Plus, patients won’t have to worry about Google or Amazon placing ads in their brains. —RD
Keep up with the innovative tech transforming business
Tech Brew keeps business leaders up-to-date on the latest innovations, automation advances, policy shifts, and more, so they can make informed decisions about tech.